Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy an safety results from a randomized, double blind, placebo-controlled trial.

Tripathy D ; Lichinitzer M ; Lazarev A ; Maclachlan SA ; Apffelstaedt J ; Budde M ; Bergstrom B (2004)



Please help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za

Journal Articles (subsidised)

Please refer to this item in SUNScholar by using the following persistent URL: http://hdl.handle.net/10019.1/78677
This item appears in the following collections: